[O1–12–01]: [18F]FLUTEMETAMOL AMYLOID SCANNING IN A PHASE III AMNESTIC MILD COGNITIVE IMPAIRMENT STUDY: ADDITIONAL INFLUENCE OF OTHER BIOMARKERS IN ESTIMATING RISK OF CONVERSION TO PROBABLE ALZHEIMERS DISEASE. (1st July 2017) - Buckley, Chris J.; Inglis, Fraser; Cherubini, Andrea; Zanette, Michelle; Farrar, Gill; Brooks, David J.; Wolk, David A.